Day: June 9, 2020

Date et heure ajoutées :MONTRÉAL, 09 juin 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) a annoncé aujourd’hui qu’elle tiendra son assemblée annuelle des actionnaires 2020 (« Assemblée ») le 18 juin à 10 h 30 HAE en format virtuel en raison de la poursuite des préoccupations de santé publique liées à la pandémie de COVID-19.L’entreprise avait annoncé antérieurement dans son avis de convocation à l’Assemblée 2020 qu’en raison des conditions et des préoccupations de santé publique, elle tiendrait son Assemblée en un format hybride où les actionnaires inscrits et les fondés de pouvoir dûment nommés pourraient participer à l’Assemblée soit en personne soit en ligne sur Internet via une webdiffusion en direct. Toutefois, en raison de la poursuite des risques associés à la pandémie de COVID-19, l’entreprise a pris la décision d’adopter...

Worldline’s Annual General MeetingOutstanding support from Worldline shareholdersfor the contemplated acquisition of Ingenico GroupApproval of all resolutionssubmitted by the Board of DirectorsBezons, 9 June 2020– Worldline [Euronext: WLN], European leader in payments and transactional services, held today its Annual General Meeting chaired by Mr. Gilles Grapinet, Chairman and Chief Executive Officer. The meeting was held behind closed doors due to current sanitary constraints and gathered, despite this special context, a quorum of 78.44%. The shareholders overwhelmingly approved the resolutions relating to the contemplated acquisition of Ingenico Group. The renewal of the term of office of Mr. Gilles Grapinet, Chairman and Chief Executive Officer for a period of three years and the Company’s “raison d’être” were also widely approved...

Assemblée Générale des ActionnairesLarge soutien des actionnaires de Worldlineau projet d’acquisition d’IngenicoApprobation de l’ensemble des résolutionssoumises par le Conseil d’AdministrationBezons, le 9 juin 2020– Worldline [Euronext: WLN], leader européen des paiements et des services transactionnels, a tenu aujourd’hui son Assemblée Générale Annuelle, présidée par Monsieur Gilles Grapinet, Président-Directeur Général. Cette assemblée s’est tenue à huis clos en raison des contraintes sanitaires actuelles et a rassemblé, malgré ce contexte particulier, un large quorum de 78,44%. Les actionnaires ont massivement approuvé les résolutions concernant le projet d’acquisition d’Ingenico. Le renouvellement du mandat de M. Gilles Grapinet, Président-Directeur Général pour une durée de trois ans et la raison d’être de la Société ont aussi été...

ALTAVISTA, Va. and DANVILLE, Va., June 09, 2020 (GLOBE NEWSWIRE) — Pinnacle Bankshares Corporation (OTCQX: PPBN) (“Pinnacle”) and Virginia Bank Bankshares, Inc. (OTC Pink: VABB) (“Virginia Bank”) today jointly announced that they will be moving forward with their planned merger and have entered into an amendment to the initial Agreement and Plan of Reorganization, dated January 21, 2020, between Pinnacle and Virginia Bank (the “Agreement”)The effects of the COVID-19 pandemic on the companies’ local economies, financial markets and other conditions prompted both companies to modify their respective financial projections and reevaluate the terms of the merger. The amendment to the Agreement was unanimously approved by the boards of directors of both companies today.Under the terms of the amended Agreement, Virginia Bank shareholders...

DENVER, June 09, 2020 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider of concrete pumping services and waste management services in the U.S. and U.K., today reported financial results for its second fiscal quarter ended April 30, 2020.Second Quarter Fiscal Year 2020 Summary vs. Second Quarter of Fiscal Year 2019Management Commentary“As indicated in our second quarter pre-announcement and further supported by today’s strong results, our business has shown resilience amongst the COVID-19 pandemic, highlighting the agility of our operations and largely essential nature of our work,” said Bruce Young, CEO of CPH. “During this time, we have prioritized the safety of our employees while continuing to deliver exceptional service that our customers demand. We also continue to...

AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) — Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US stock market opens on June 29, 2020, according to a preliminary list of additions posted on June 5, 2020.Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 8, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership...

Denali and Sanofi pause DNL747(a) clinical activities based on the totality of DNL747 data and a superior profile of backup compound DNL788(b)Denali and Sanofi intend to accelerate DNL788 for development in neurological indications, with plans to initiate clinical testing by early 2021Safety endpoints were met in Phase 1b patient studies with DNL747 in ALS and Alzheimer’s disease, however further dose escalation to achieve higher levels of target inhibition may be limited by preclinical chronic safety dataSanofi successfully completed the Phase 1 healthy volunteer study with peripherally-restricted RIPK1 inhibitor DNL758(c), and further clinical studies in multiple indications are being plannedSOUTH SAN FRANCISCO, June 09, 2020 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad...

TORONTO, June 09, 2020 (GLOBE NEWSWIRE) — INV Metals Inc. (“INV Metals” or the “Company”) (TSX:INV) is pleased to announce it will be hosting its second Live Town Hall Webinar (“Webinar”) with O&M Partners on Tuesday, June 16, 2020 at 2:15 p.m. EDT.INV Metals is focused on the sustainable development of the Loma Larga gold, copper and silver project (“Loma Larga”) and on the exploration of its greenfields projects, located in Ecuador. Please join the Company’s Chief Executive Officer, Ms. Candace MacGibbon, for an overview of the Company and Ecuador, highlighting INV Metals’ permitting and financing efforts within 2020 to advance Loma Larga towards development.Ms. MacGibbon commented, “We continue to advance our permitting efforts for Loma Larga and are also focused on securing financing for Loma Larga as demonstrated by the...

MILWAUKEE, June 09, 2020 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its assets under management (“AUM”) as of May 31, 2020 totaled $114.4 billion. Separate accounts1 accounted for $60.7 billion of total firm AUM, while Artisan Funds and Artisan Global Funds accounted for $53.7 billion.1 Separate account AUM consists of the assets we manage in or through vehicles other than Artisan Funds or Artisan Global Funds. Separate account AUM includes assets we manage in traditional separate accounts, as well as assets we manage in Artisan-branded collective investment trusts, in funds (both public and private) that we sub-advise, and in our own privately offered funds.2 Other Assets Under Management includes AUM managed by the Credit Team in the Credit Opportunities strategy and by...

SOUTH SAN FRANCISCO, Calif., June 09, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Lori Kunkel, M.D., to its board of directors. Dr. Kunkel brings more than twenty-five years of experience in oncology and immunology drug development and commercialization.“We are delighted to welcome Lori to our board of directors as ORIC embarks on this next phase of its evolution,” said Jacob Chacko, M.D., chief executive officer. Over a multi-decade career, Lori has made significant contributions as a clinician, academic and highly respected leader in the biotechnology community, and has played a key role in the development, approval and commercialization of multiple innovative...